Skip to content
ETopical – Lifestyle
Home
Sample Page
Author:
Juniper Biosciences
Juniper’s JBS-003 (F-MISO) Program Receives FDA Breakthrough Therapy Designation, Advancing a First-in-Class Hypoxia Tracer Enabling Radiation De-escalation in HPV-Positive Head and Neck Cancer
September 1, 2026
Juniper Biosciences Appoints Renowned Radiopharmaceutical Expert Jason S. Lewis, Ph.D. as Chair of Newly Formed Scientific Advisory Board
May 18, 2026
Juniper Biosciences Announces Strategic Collaboration with leading global cancer center on F-MISO (JBS-003): A First-in-Class Precision Diagnostic Poised to Revolutionize Head and Neck Cancer Treatment
April 28, 2026